Quarterly report pursuant to Section 13 or 15(d)

Investments

v2.4.0.8
Investments
9 Months Ended
Sep. 27, 2013
Investments [Abstracts]  
Investments
INVESTMENTS
Investments in debt and marketable equity securities, other than investments accounted for under the equity method, are classified as trading, available-for-sale or held-to-maturity. Our marketable equity investments are classified as either trading or available-for-sale with their cost basis determined by the specific identification method. Realized and unrealized gains and losses on trading securities and realized gains and losses on available-for-sale securities are included in net income. Unrealized gains and losses, net of deferred taxes, on available-for-sale securities are included in our condensed consolidated balance sheets as a component of accumulated other comprehensive income ("AOCI"), except for the change in fair value attributable to the currency risk being hedged. Refer to Note 5 for additional information related to the Company's fair value hedges of available-for-sale securities.
Our investments in debt securities are carried at either amortized cost or fair value. Investments in debt securities that the Company has the positive intent and ability to hold to maturity are carried at amortized cost and classified as held-to-maturity. Investments in debt securities that are not classified as held-to-maturity are carried at fair value and classified as either trading or available-for-sale.
Trading Securities
As of September 27, 2013, and December 31, 2012, our trading securities had a fair value of $314 million and $266 million, respectively, and consisted primarily of equity securities. The Company had net unrealized gains on trading securities of $28 million and $19 million as of September 27, 2013, and December 31, 2012, respectively. The Company's trading securities were included in the following line items in our condensed consolidated balance sheets (in millions):
 
September 27,
2013

December 31,
2012

Marketable securities
$
231

$
184

Other assets
83

82

Total trading securities
$
314

$
266


Available-for-Sale and Held-to-Maturity Securities
As of September 27, 2013, available-for-sale securities consisted of the following (in millions):
 
 
Gross Unrealized
 
 
Cost

Gains

Losses

Fair Value

Available-for-sale securities:1
 
 
 
 
Equity securities
$
983

$
389

$
(15
)
$
1,357

Debt securities
3,343

21

(34
)
3,330

Total available-for-sale securities
$
4,326

$
410

$
(49
)
$
4,687


1 Refer to Note 14 for additional information related to the estimated fair value.
As of December 31, 2012, available-for-sale securities consisted of the following (in millions):
 
 
Gross Unrealized
 
 
Cost

Gains

Losses

Fair Value

Available-for-sale securities:1
 
 
 
 
Equity securities
$
957

$
441

$
(10
)
$
1,388

Debt securities
3,169

46

(10
)
3,205

Total available-for-sale securities
$
4,126

$
487

$
(20
)
$
4,593

1 Refer to Note 14 for additional information related to the estimated fair value.
The sale and/or maturity of available-for-sale securities resulted in the following realized activity during the three and nine months ended September 27, 2013, and September 28, 2012 (in millions):
 
Three Months Ended
 
Nine Months Ended
 
September 27,
2013

September 28,
2012

 
September 27,
2013

September 28,
2012

Gross gains
$
2

$
22

 
$
10

$
34

Gross losses
(9
)
(26
)
 
(19
)
(28
)
Proceeds
1,091

1,256

 
3,349

4,098


The Company uses one of its insurance captives to reinsure group annuity insurance contracts that cover the pension obligations of certain of our European pension plans. In accordance with local insurance regulations, our insurance captive is required to meet and maintain minimum solvency capital requirements. The Company elected to invest its solvency capital in a portfolio of available-for-sale securities, which are classified in the line item other assets in our condensed consolidated balance sheets because the assets are not available to satisfy our current obligations. As of September 27, 2013, and December 31, 2012, the Company's available-for-sale securities included solvency capital funds of $530 million and $451 million, respectively.
The Company's available-for-sale securities were included in the following line items in our condensed consolidated balance sheets (in millions):
 
September 27,
2013

December 31,
2012

Cash and cash equivalents
$
76

$
9

Marketable securities
2,971

2,908

Other investments, principally bottling companies
993

1,087

Other assets
647

589

Total available-for-sale securities
$
4,687

$
4,593


The contractual maturities of these available-for-sale securities as of September 27, 2013, were as follows (in millions):
 
Cost

Fair Value

Within 1 year
$
1,285

$
1,267

After 1 year through 5 years
1,574

1,580

After 5 years through 10 years
149

153

After 10 years
335

330

Equity securities
983

1,357

Total available-for-sale securities
$
4,326

$
4,687


The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
As of September 27, 2013, and December 31, 2012, the Company did not have any held-to-maturity securities.
Cost Method Investments
Cost method investments are initially recorded at cost, and we record dividend income when applicable dividends are declared. Cost method investments are reported as other investments in our condensed consolidated balance sheets, and dividend income from cost method investments is reported in other income (loss) — net in our condensed consolidated statements of income. We review all of our cost method investments quarterly to determine if impairment indicators are present; however, we are not required to determine the fair value of these investments unless impairment indicators exist. When impairment indicators exist, we generally use discounted cash flow analyses to determine the fair value. We estimate that the fair values of our cost method investments approximated or exceeded their carrying values as of September 27, 2013, and December 31, 2012. Our cost method investments had a carrying value of $157 million and $145 million as of September 27, 2013, and December 31, 2012, respectively.